It is worth mentioning that the HDAC1-HDAC7-ZNF92 axis and their 29 downstream targets are rarely mutated in human breast cancers, consistent with a cell-of-origin signature (Figure S5 and Table S4). This evidence concerns the gene HDAC1 and breast cancer.